The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
196 reports and counting
Beam Therapeutics Raises $206M in Series C
Beam Therapeutics, a Biotech company based in 238 Main Street, Cambridge, MA 02142, has raised $206M in Series C at a $3.5B valuation led by Foresite Capital, F-Prime Capital, Omega Funds, Redmile Group, Wellington Management.
Beam Therapeutics raises $206M Series C at $3.5B valuation
Beam Therapeutics raises $206M in Series C at $3.5B valuation. Base editing technology...
Beam Therapeutics Headquarters - Office Location & Address
Discover Beam Therapeutics's headquarters at 238 Main St, Cambridge, MA 02142. Base editing therapeutics developer. Learn about the office facilities and work environment.
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Denali Therapeutics raises $217M Series C at $5B valuation
Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Kailera Therapeutics raises $400M Series A at $1.5B valuation
Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.